-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WWFjCoZOC3pj2dCykUHKJiMSsMbyskWMa0OY5xVR2euO1eFIsMPtwfIjlWawMIax tkvgjsA5KmOosnM+dMVlmw== 0000950123-97-001710.txt : 19970228 0000950123-97-001710.hdr.sgml : 19970228 ACCESSION NUMBER: 0000950123-97-001710 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19970227 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BRITISH BIOTECHNOLOGY PLC CENTRAL INDEX KEY: 0001032171 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48835 FILM NUMBER: 97545512 BUSINESS ADDRESS: STREET 1: WATLINGTON ROAD CITY: COWLEY OXFORD STATE: X0 ZIP: 00000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAT INDUSTRIES PLC /FI CENTRAL INDEX KEY: 0000799853 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: P O BOX 345 STREET 2: 50 VICTORIA ST WINDSOR HOUSE CITY: LONDON ENGLAND STATE: X0 ZIP: 00000 BUSINESS PHONE: 01101712227979 MAIL ADDRESS: STREET 1: WINDSOR HOUSE STREET 2: 50 VICTORIA STREET CITY: LONDON ENGLAND STATE: X0 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BAT INDUSTRIES PLC /FI DATE OF NAME CHANGE: 19950214 SC 13G/A 1 AMENDMENT #1 TO SCHEDULE 13G 1 ------------------------- OMB APPROVAL ------------------------- OMB NUMBER: 3235-0145 Expires:December 31, 1997 Estimated average burden hours per response..14.90 ------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1 )* BRITISH BIOTECH PLC (Name of Issuer) Common Stock, par value (pound)0.05 per share (Title of Class of Securities) 110515103 (CUSIP Number) Check the following box if a fee is being paid with this statement / / . (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 13 pages 2 - ------------------------------- --------------------------------- CUSIP NO. 110515103 13G PAGE 2 OF 8 PAGES - ------------------------------- --------------------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON B.A.T Industries p.l.c. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF SHARES ------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY EACH 2,638,880 REPORTING PERSON ------------------------------------------------------------- WITH 7 SOLE DISPOSITIVE POWER -0- ------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 2,638,880 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,638,880 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / N.A. - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 13 pages 3 Items 4 and 5 of the Statement on Schedule 13G, dated February 5, 1997, filed by B.A.T Industries p.l.c. and Farmers Group, Inc., is hereby amended and restated to read in their entirety as follows: Item 4 Ownership (a) Amount Beneficially Owned 2,638,880 (b) Percent of Class: 0.4% (c) Number of shares as to which person has: (i) Sole voting power: -0- (ii) Shared voting power: 2,638,880 (iii) Sole disposition power: -0- (iv) Shared disposition power: 2,638,880 Item 5 Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following box. /X/ . Page 3 of 13 pages 4 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. B.A.T INDUSTRIES p.l.c. Dated February 25, 1997 By: /s/ Anthony Robert Holliman --------------------------------------- Name: Anthony Robert Holliman Title: Assistant Corporate Secretary Page 4 of 13 pages 5 Exhibit Index
Exhibit Description Page Number - ------- ----------- ----------- I Schedule 13G, dated February 5, 1997 6
Page 5 of 13 pages EX-99.I 2 ORIGINAL SCHEDULE 13G 1 ------------------------- OMB APPROVAL ------------------------- OMB NUMBER: 3235-0145 Expires:December 31, 1997 Estimated average burden hours per response..14.90 ------------------------- Exhibit I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. )* BRITISH BIOTECH PLC (Name of Issuer) Common Stock, par value (pound)0.05 (Title of Class of Securities) per share 110515103 (CUSIP Number) Check the following box if a fee is being paid with this statement /X/ . (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 6 of 13 pages 2 - ------------------------------- --------------------------------- CUSIP NO. 110515103 13G PAGE 2 OF 8 PAGES - ------------------------------- --------------------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON B.A.T Industries p.l.c. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / / (b) / / - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION England - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER -0- NUMBER OF SHARES -------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY EACH 2,638,880 REPORTING PERSON -------------------------------------------------------------- WITH 7 SOLE DISPOSITIVE POWER -0- -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 2,638,880 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,638,880 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / / N.A. - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.30% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* HC - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 7 of 13 pages 3 Item 1 (a). Name of Issuer: BRITISH BIOTECH PLC Item 1 (b). Address of Issuer's Principal Executive Office: Watlington Road Dowley Oxford OX4 5LY England Item 2(a). Name of Person Filing: B.A.T Industries p.l.c., an English corporation ("B.A.T"). Item 2(b). Address of Principal Business Office or, if none, Residence: B.A.T Industries p.l.c. Windsor House 50 Victoria Street London SW1H ONL England Item 2(c). Citizenship: B.A.T Industries p.l.c. - England Item 2(d). Title of Class of Securities: Common stock, par value (pound)0.05 per share Item 2(e). CUSIP Number: 110515103 Item 3. This statement is filed pursuant to Rule 13d-1(b) by B.A.T, a Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G). Page 8 of 13 pages 4 Item 4. Ownership: (a) Amount Beneficially Owned: 2,638,880 The shares being reported were acquired by various investment funds for which subsidiaries of B.A.T act as manager and investment adviser and exercise investment discretion. No such subsidiary beneficially owns in excess of 5% of the class of shares for which this report is being made. The filing of this statement by B.A.T shall not be construed as an admission that B.A.T is, for the purposes of Section 13(d) or 13(g) of the Act or under the laws or regulations of the United Kingdom, the beneficial owner of any securities covered by this statement. (b) Percent of Class: 7.30% (c) Number of shares as to which person has: (i) Sole voting power: -0- (ii) Shared voting power: 2,638,880 (iii) Sole disposition power: -0- (iv) Shared disposition power: 2,638,880 Item 5. Ownership of Five Percent or Less of a Class: Not Applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: See Exhibit I. Item 8. Identification and Classification of Members of the Group: Not Applicable. Page 9 of 13 pages 5 Item 9. Notice of Dissolution of the Group: Not Applicable. Item 10. Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. Page 10 of 13 pages 6 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. B.A.T INDUSTRIES p.l.c. Dated February 5, 1997 By: /s/ Anthony Robert Holliman ----------------------------- Name: Anthony Robert Holliman Title: Assistant Corporate Secretary Page 11 of 13 pages 7 Exhibit Index
Exhibit Description Page Number - ------- ----------- ----------- I Identification and Classification of Subsidiaries 13
Page 12 of 13 pages 8 Exhibit I The shares of BRITISH BIOTECHN PLC which are the Subject of this Schedule 13G were acquired by various investment funds for which subsidiaries of B.A.T. act as manager and investment adviser and exercise investment discretion. The identity of such subsidiaries is as follows: Eagle Star Life Assurance Company Limited 60 St. Mary Axe London EC3A 8JQ England Eagle Star Insurance Company Limited 60 St. Mary Axe London EC3A 8JQ England Eagle Star Reinsurance Company Limited 60 St. Mary Axe London EC3A 8JQ England Each of the foregoing subsidiaries is an insurance company for purposes of Item 3 of this Statement. Page 13 of 13 pages -----END PRIVACY-ENHANCED MESSAGE-----